Record highs for US markets: What it means for KiwiSaver investors
KiwiSaver funds have about $35 billion in US equities.
AdvertisementAdvertise with NZME.
Latest from Stock takes
Stock Takes: Why NZ's sharemarket is falling behind global counterparts
The New Zealand sharemarket has fallen 5% in the first half, while others have gained.
Stock Takes: In play - more firms eyed for takeover as economy remains sluggish
BGH's tilt at Tourism Holdings has sparked more merger and acquisition speculation.
Stock Takes: Why NZ's largest firms are suddenly ripe for takeover talks
Fletcher Building, Spark and Ryman are potentially all on the radar.
Stock Takes: Why more Kiwis are taking a punt on Wall St
Plus: Auckland Airport and Spark are back in favour with analysts at Morningstar.
'Morbid fascination': Bond yield spikes unsettle investors
Rising world bond yields are unsettling sharemarket investors.
Sybos sells $951.9m in Ebos shares, reduces stake to 4.9%
Sybos sold 27m Ebos shares - first sale since 2020.
Stock Takes: Why Ryman Healthcare has fallen out of favour with investors
An overhang on the stock is weighing on the retirement village operator's share price.
Stock Takes: 'Unlikely to impact' - analyst downplays Fonterra-Bega legal dispute
Analyst says risks in Fonterra-Bega legal tangle have been overstated.
Stock Takes: Will reporting season see the end of a bear market?
Fisher and Paykel Healthcare will be the main event when it reports on May 28.
Stock Takes: Rain not enough to stop dry weather from hurting NZ power company earnings
Mercury, Meridian and Manawa are likely to be hit hardest by the earlier drought.
Spark auctioning half its data centre business to fund $1b expansion push: report
Surf's up for the telco as its capital-raising effort comes to the sharp end.
Tech Insider: Blackbird partner says Govt made mistake giving up on $300m Elevate fund
PLUS: Blackbird gears up for $1 billion raise.
Stock Takes: NZ shares are down, but not out
New Zealand's sharemarket is in correction mode, but is faring better than others.
Stock Takes: Who’s lining up to buy Fonterra’s Mainland and how much is it worth?
Fonterra's Mainland sale process continues despite a turbulent sharemarket.
Stock Takes: How Sharesies investors responded to ‘Liberation Day ’ convulsions
Sharesies investors have opted to play safe during convulsions on world markets.
What’s next for NZ stocks after a poor first quarter? Stock Takes
New Zealand shares suffered a poor first quarter, driven by sickly corporate earnings.
Stock Takes: Has ethical investing lost its shine?
The change of Government in the United States has put ESG investing on the back foot.
Stock Takes: Is gold a good bet?
Gold has hit a record high this week but is it a good investment?
Stock Takes: Focus turns to second half after RBNZ rate cut
Focus has turned to those companies who will benefit from this week's RBNZ rate cut.
Stock Takes: Will NZ corporate earnings offer green shoots for the economy?
The reporting season gets fully underway next week. Will there be green shoots?
Stock Takes: Why the NZ sharemarket is lagging the rest
There are some stark contrasts between the local index and other comparable markets.
Stock Takes: Better times ahead for NZX-listed dairy companies?
Synlait is back in action after a terrible 2024, while trade tension overhangs FPH.
Stock Takes: Air NZ banks on loyal fliers for revenue boost
Analysts upgrade airline's rating but are dubious about some of its revenue plans.
Stock Takes: The big issues facing F&P Healthcare
F&P Healthcare's share price has held despite concerns about the US health sector.
Stock Takes: Why a2 is out of favour, and a role reversal for Fonterra
Private equity is seen as a likely buyer for Fonterra's consumer business.
'Money for jam': How much bankers made from Auckland Airport’s whopper capital raise
Plus: Sky TV gets a thumbs-up for its deal-making skills.
Stock Takes: A capital raise for Infratil? Comvita’s mystery bidder
How will Infratil fund its ambitious plans for its Aussie data centre business?
Stock Takes: F&P Healthcare rebounds, tech sector surges and what next for cannabis company?
F&P Healthcare recovers after a sell-off, and what's in store now for Cannasouth.
Stock Takes: Life in the fast lane - the auto stocks bucking NZ’s downtrend
And will new car dealership Armstrong’s try listing on the sharemarket again?
Stock Takes: Why a $4 billion deal fell over
The failed Ebos deal would have been a big bite for investors.
Stock Takes: NZ Shareholders Association on seeing the wood for the trees
The NZSA has questioned the timeliness of PGW's disclosure.
Is this tech company the next Xero?
This freshly listed tech start-up is back by Sir Owen Glenn.
'NZ is in a tough patch': Why our economy is looking like the US during the GFC
Fisher Funds' Ashley Gardyne weighs in on how markets have performed.